What is Bloomer Tech?
Bloomer Tech specializes in generating digital biomarkers specifically for women's health, focusing on precision cardiovascular care. Their innovative technology provides real-time insights and comprehensive data to assist clinicians in recognizing and diagnosing heart disease in women. The company aims to empower women worldwide by leveraging female physiology in their healthcare solutions, addressing a critical gap in personalized medicine.
How much funding has Bloomer Tech raised?
Bloomer Tech has raised a total of $3M across 1 funding round:
Angel/Seed
$3M
Angel/Seed (2020): $3M with participation from One Brave Idea and Material Impact
Key Investors in Bloomer Tech
One Brave Idea
One Brave Idea is an innovation engine focused on tackling healthcare's biggest challenges through bold, transformative ideas. They invest in and support ventures that have the potential for significant impact on patient outcomes and the healthcare system.
Material Impact
Material Impact is focused on building deep tech companies that leverage material science to drive innovation. They invest in first-of-their-kind technologies and support founders to create impactful solutions that enhance productivity and sustainability.
What's next for Bloomer Tech?
With this major enterprise-level funding, Bloomer Tech is poised to accelerate its research and development efforts. The strategic investment will likely fuel the expansion of their biomarker generation capabilities and enhance their data analytics platform. Future growth will probably involve deeper clinical validation and broader market penetration, solidifying their position as a leader in women's cardiovascular health technology.
See full Bloomer Tech company page
